ATLAS / Macro Radar / Reporting / PTGX

Protagonist Therapeutics, Inc (PTGX) reporting calendar

Protagonist Therapeutics, Inc files periodic reports with the SEC as PTGX on Nasdaq. Atlas tracks 40 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
27 Jul 2026 – 16 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
40

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open PTGX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001104659-26-055661
10-K31 Dec 202525 Feb 202656 days0001104659-26-019696
10-Q30 Sep 20256 Nov 202537 days0001104659-25-107816
10-Q30 Jun 20256 Aug 202537 days0001558370-25-010534
10-Q31 Mar 20256 May 202536 days0001558370-25-006530
10-K31 Dec 202421 Feb 202552 days0001558370-25-001317
10-Q30 Sep 20247 Nov 202438 days0001558370-24-014888
10-Q30 Jun 20246 Aug 202437 days0001558370-24-011095
10-Q31 Mar 20247 May 202437 days0001558370-24-007081
10-K31 Dec 202327 Feb 202458 days0001558370-24-001850
10-Q30 Sep 20232 Nov 202333 days0001558370-23-017460
10-Q30 Jun 20233 Aug 202334 days0001558370-23-013245
10-Q31 Mar 20234 May 202334 days0001558370-23-008137
10-K31 Dec 202215 Mar 202374 days0001558370-23-003906
10-Q30 Sep 20228 Nov 202239 days0001558370-22-016908
10-Q30 Jun 20224 Aug 202235 days0001558370-22-012277
10-Q31 Mar 20225 May 202235 days0001558370-22-007438
10-K31 Dec 202128 Feb 202259 days0001558370-22-002385
10-Q30 Sep 20213 Nov 202134 days0001558370-21-014338
10-Q30 Jun 20214 Aug 202135 days0001558370-21-010244
10-Q31 Mar 20214 May 202134 days0001558370-21-005733
10-K31 Dec 202010 Mar 202169 days0001558370-21-002715
10-Q30 Sep 20204 Nov 202035 days0001558370-20-012597
10-Q30 Jun 20206 Aug 202037 days0001558370-20-009681
10-Q31 Mar 20207 May 202037 days0001558370-20-005785
10-K31 Dec 201910 Mar 202070 days0001558370-20-002334
10-Q30 Sep 20196 Nov 201937 days0001558370-19-010201
10-Q30 Jun 20197 Aug 201938 days0001558370-19-007515
10-Q31 Mar 20198 May 201938 days0001558370-19-004481
10-K31 Dec 201812 Mar 201971 days0001558370-19-001853
10-Q30 Sep 20186 Nov 201837 days0001558370-18-008657
10-Q30 Jun 20187 Aug 201838 days0001558370-18-006639
10-Q31 Mar 20189 May 201839 days0001558370-18-004498
10-K31 Dec 20177 Mar 201866 days0001558370-18-001637
10-Q30 Sep 20177 Nov 201738 days0001377121-17-000007
10-Q30 Jun 20178 Aug 201739 days0001628280-17-008339
10-Q31 Mar 201710 May 201740 days0001377121-17-000003
10-K31 Dec 20167 Mar 201766 days0001193125-17-073383
10-Q30 Sep 201614 Nov 201645 days0001193125-16-767928
10-Q30 Jun 201615 Sep 201677 days0001193125-16-710986

Source: SEC EDGAR company submissions for CIK 0001377121. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.